Testing effectiveness (Phase 2)Study completedNCT03060577
What this trial is testing
An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol
Who this might be right for
Atherosclerotic Cardiovascular DiseaseSymptomatic AtherosclerosisType2 Diabetes+1 more
Novartis Pharmaceuticals 382